The Heritage of Hepatitis B Vaccine
Abstract
Pioneering development of the plasma-derived and yeast-derived recombinant hepatitis B vaccines represents a major contribution to preventive health care of this century. Current and expanding worldwide application of hepatitis B vaccine promises to eliminate and eventually eradicate hepatitis B infection from the human population and, with it, many cases of cirrhosis and cancer of the liver.
Footnotes
-
Reprints: R. Gordon Douglas, Jr, MD, Merck Vaccine Division, Merck & Co Inc, One Merck Dr, PO Box 100, Whitehouse Station, NJ 08889-0100.
-
A commentary on Buynak EB, Roehm RR, Tyteli AA, Bertiand AU II, Lampson GP, Hilleman MR. Vaccine against human hepatitis B. JAMA. 1976;235:2832-2834.
